Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myeloproliferative Neoplasms (MPN) and COVID-19

NCT04385160 is registered in ClinicalTrials.gov with FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS as lead sponsor.

NCT NCT04385160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myeloproliferative Neoplasms (MPN) and COVID-19
Lead sponsor
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Phase
Observational
Overall status
Completed
Start date
May 13, 2020
Completion date
August 31, 2022
Enrollment
552 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

covid, myeloproliferative neoplasm